Related by context. All words. (Click for frequent words.) 62 cytomegalovirus 61 HBV 59 HCV 59 VZV 57 cytomegalovirus CMV 57 CMV infection 57 HBsAg 57 neutralizing antibodies 56 K#R [002] 55 RhD negative 55 K#N 55 NRTI resistance 55 M#V mutation 55 CD8 responses 55 RhD 55 autoantibodies 55 antibodies 55 transgene expression 55 MTHFR 54 HbF 54 viremia 54 WT1 54 Rh positive 54 immunocompetent 54 chlamydial 54 IgM antibodies 54 CD# [002] 54 CMV disease 54 HLA A2 54 aT cell 54 HER2/neu 54 effector memory 54 N. meningitidis 54 iNOS 54 serogroup 54 hepatitis C virus 54 IgM 54 herpes simplex virus 54 NNRTI 54 FLT3 54 coinfection 54 TLR3 53 HPV# 53 pDCs 53 humanized antibody 53 PTLD 53 TNFa 53 immune responses 53 seronegative 53 antigen 53 antibody 53 germline mutations 53 Trichomonas vaginalis 53 herpesviruses 53 BVDV 53 Respiratory Syncytial Virus RSV 53 rhIL 7 53 HCV infection 53 NNRTI resistant virus 53 lymphoid organs 53 congenital CMV infection 53 hypermethylation 53 Human Papilloma Virus 53 HHV 6 52 pneumococcal serotypes 52 JAK2 52 T SPOT.TB 52 enterococcal 52 EBV 52 antibody mediated 52 murine 52 HBV infection 52 pertussis toxin 52 latent tuberculosis infection 52 BRAF mutation 52 pneumococci 52 heterologous 52 CD8 + 52 serotype #A 52 interferon IFN 52 hepatitis C HCV 52 antigens 52 TNFalpha 52 microsatellite instability 52 Epstein Barr virus EBV 52 TNF α 52 hepatitis B infection 52 NRTI 52 hMPV 52 HPV genotypes 52 TEL AML1 52 C. trachomatis 52 IFNg 52 TAp# 52 ERCC1 52 granulocyte 52 Cytomegalovirus 52 BCG vaccinated 52 nucleoside analogues 51 nucleoside 51 EGFRvIII 51 Hepatitis B Virus 51 huntingtin gene 51 coagulase negative staphylococci 51 hepatitis B virus HBV 51 superinfection 51 effector function 51 APTIMA R 51 germline mutation 51 IgG antibodies 51 Cytomegalovirus CMV 51 humoral responses 51 genital ulcer disease 51 surface antigen HBsAg 51 hepatoma 51 pancreatic islet 51 Gleevec resistant 51 neutralizing antibody 51 HCV antibodies 51 QuantiFERON 51 IFN ß 51 viraemia 51 Epidermal Growth Factor Receptor 51 IgA antibodies 51 varicella zoster virus VZV 51 HPV 51 IL 1ß 51 NNRTIs 51 chronic HBV 51 PGE2 51 gamma globin gene 51 oncogenic HPV 51 JAK3 51 HBeAg negative 51 Hepatitis B virus 51 antibody titer 51 latent TB infection 51 uPA 51 Neisseria meningitidis 51 specific CD8 + 51 BRCA mutation 51 Septin 9 51 Amplicor 51 UGT#A# 51 T1DM 51 breast carcinomas 51 KSHV 51 Candida infection 51 TNFα 51 BRAF gene 51 CD8 T cells 51 co stimulatory molecules 51 virulence genes 51 Symadex 51 immunosuppressed patients 51 IgM antibody 51 humanized monoclonal antibody 51 pneumococcal infection 51 syngeneic 51 VEGF receptor 51 immunological 51 CCR5 tropic HIV 51 Human Papillomavirus HPV 51 tumor antigen 51 promoter methylation 51 highly pathogenic influenza 51 MAb 51 innate immune responses 51 latently infected 50 Pharmacokinetics PK 50 antibody responses 50 CCR9 50 MYH9 gene 50 HIV RNA 50 granulocytes 50 NPM1 mutation 50 multidrug resistance 50 ovarian carcinoma 50 tuberculin skin testing 50 BCL#A 50 Respiratory Virus 50 autoimmunity 50 nucleotide analog 50 serogroup C 50 IFN gamma 50 prostate cancer CaP 50 lymphocytes 50 mGluR 50 peptide antigens 50 HLA B 50 vaccine serotypes 50 thyroglobulin 50 PCV2 50 renal fibrosis 50 seropositivity 50 cytotoxicity 50 mediated immunity 50 EGFr 50 Neisseria gonorrhoeae 50 polysaccharide vaccines 50 lymphotoxin 50 KRAS oncogene 50 serogroups 50 CMV reactivation 50 HBV vaccine 50 S aureus 50 Clusterin 50 autoantibody 50 CCR5 inhibitor 50 Foxp3 50 HLA antibody 50 Chlamydia trachomatis 50 IgG 50 Th# cells 50 CTLs 50 inhibit replication 50 androgen receptor AR 50 HDACi 50 hTERT 50 MDA MB 50 genital tract 50 MUC1 protein 50 VEGFR2 50 chemokine receptor 50 Leydig cells 50 thymocytes 50 chlamydial infection 50 IGFBP 3 50 NY ESO 50 squamous intraepithelial lesions 50 mAb 50 NNRTI resistance 50 4CMenB 50 ganciclovir 50 replicon 50 trophoblast cells 50 virologic failure 50 orthopoxvirus 50 T#M mutation 50 gamma interferon 50 M. bovis 50 adenoviral 50 papillomavirus 50 CMV vaccine 50 antiviral therapy 50 survivin 50 IgG1 50 pyruvate kinase 50 Flt3 50 CXCR4 50 CD4 + T 50 rotaviruses 50 M#V 50 MIF gene 50 HIV uninfected 50 EpCAM 50 herpes zoster shingles 50 tryptase 49 CD4 + CD# 49 JEV 49 serologic 49 HLA B# 49 quadrivalent vaccine 49 HIV1 49 S. aureus 49 conjugate vaccine 49 Idiopathic Thrombocytopenic Purpura ITP 49 S. aureus infection 49 immunological responses 49 S. pneumoniae 49 NFkB 49 PDGF receptor 49 GFAP 49 Balamuthia 49 epitope 49 myeloproliferative 49 DermaVir Patch 49 Herpes Simplex Virus 49 neuroblastoma tumors 49 TLR9 49 activating mutation 49 ELISpot 49 methylated DNA 49 HER2 gene 49 rabbit polyclonal 49 GSTP1 49 Akt signaling 49 plasmacytoid dendritic cells 49 PBMCs 49 protease inhibitor 49 N. gonorrhoeae 49 Epratuzumab 49 lentiviral vector 49 lupus anticoagulant 49 cervical lesions 49 vidofludimus 49 ELISPOT 49 H. influenzae 49 virus HBV 49 HCV antibody 49 erythropoietic 49 varicella zoster virus 49 genotypic resistance 49 capsular polysaccharide 49 low expressors 49 HSV1 49 CLL cells 49 c myc 49 lamivudine resistant 49 TGF β 49 NF kB pathway 49 NOD SCID mice 49 eczema vaccinatum 49 transfected 49 oncogenic transformation 49 vWF 49 RASSF1A 49 etiologic agent 49 genital herpes infections 49 asymptomatic carriers 49 Mutational 49 BALB c mice 49 isotypes 49 hyperbilirubinemia 49 epithelial tumors 49 antibody titers 49 JAK2 enzyme 49 rheumatoid factor 49 HPV subtypes 49 c MET 49 KRAS mutation 49 TG# [001] 49 adenovirus 49 CsA 49 Adhibit 49 GRNOPC1 cells 49 TYZEKA 49 HLA DQ2 49 Vacc 4x 49 Gleevec imatinib mesylate 49 trichomonas 49 monoclonal 49 coreceptor 49 ara C 49 immunomodulator 49 Tumor Necrosis Factor 49 E selectin 49 HIV HCV coinfected 49 CCR5 tropic 49 LTBI 49 subclinical 49 relapsed MM 49 p#INK#a 49 human leukocyte antigens 49 p# MAPK 49 HER-2/neu 49 humoral immunity 49 HCV Genotype 49 genital ulcers 49 Staphylococcus aureus infections 49 nelfinavir 49 FGFR2 49 Salmonella typhi 49 BRCA2 gene 49 Epstein Barr virus 49 thyroid hormone receptor 49 chlamydia sexually transmitted 49 lentiviral 49 CIN2 + 49 BRCA deficient 49 HPV infection 49 precursor lesions 49 thymidine kinase 49 PTPN# 49 latent tuberculosis TB 49 pharmacologic intervention 49 topical microbicide 49 thrombopoietin 49 T. vaginalis 49 Th1 49 fluoroquinolone resistance 49 interferon pathway 49 leptin receptor 49 S OIV 49 FOXP3 49 monoclonal antibody MAb 49 K ras 49 monocyte 49 HepG2 cells 49 neoplasias 48 Human Papillomavirus 48 MIF protein 48 BCR ABL 48 MVA BN R 48 combination antiretroviral therapy 48 vesicular stomatitis virus 48 activin 48 sero positive 48 Squamous 48 hemolytic disease 48 elvucitabine 48 HCV replicon 48 Notch1 48 Janus kinase 48 proto oncogene 48 Maribavir 48 cervical intraepithelial neoplasia 48 interferon γ 48 Human papillomavirus 48 PCa 48 NF kB activation 48 AAV2 48 ErbB3 48 Bordetella pertussis 48 Pneumocystis carinii pneumonia 48 K ras mutations 48 Helicobacter pylori H. pylori 48 conjugate vaccines 48 HER2 overexpression 48 TLR2 48 rhinovirus infections 48 attenuated strain 48 intestinal epithelial cells 48 pDC 48 leukocyte adhesion 48 HPV-#/# 48 selectively binds 48 cytopathic 48 endometrial hyperplasia 48 ABCB1 48 Zolinza 48 Acute Radiation Syndrome ARS 48 T gondii 48 Teriflunomide 48 GM CSF 48 congenital cytomegalovirus 48 trivalent influenza vaccine 48 HBx 48 EGFR mutation 48 CD4 lymphocyte count 48 ZFN modified cells 48 tetravalent vaccine 48 immunopathology 48 cytotoxic T lymphocytes 48 ectopic expression 48 ACTH 48 parainfluenza virus 48 hematopoietic progenitors 48 oncoprotein 48 selective inhibition 48 chronic hepatitis 48 JCV 48 serologically 48 Leydig cell 48 transgenic rats 48 steroidogenesis 48 Multidrug resistant 48 inhibitory receptor 48 Pgp 48 immunosuppressive regimens 48 CD8 T cell 48 cervical HPV 48 tumorigenicity 48 Immunohistochemical analysis 48 leukemic cells 48 estrogen receptor ER 48 severe hyperbilirubinemia 48 CCR5 inhibitors 48 solithromycin 48 antibody MAb 48 PIK3CA 48 cellular cytotoxicity 48 Plasmodium falciparum 48 Coxsackievirus 48 seroconversion 48 CMV retinitis 48 Aurora kinase 48 effector T 48 immunosuppressed 48 seropositive 48 XmAb# 48 CC genotype 48 HSV2 48 transaminase elevations 48 Candida species 48 GARDASIL ® 48 ALT flares 48 tissue transglutaminase 48 H. pylori infection 48 Genital herpes 48 HER2 positive cancers 48 Allogeneic 48 IKKa 48 CDKN2A 48 virologic 48 virions 48 nucleoside analogue 48 leukocyte recruitment 48 histological subtype 48 adipogenic 48 HepC 48 IL 1beta 48 metastatic neuroendocrine tumors 48 p#NTR 48 H pylori 48 RAS pathway 48 adenovirus serotype 5 48 Mantoux test 48 beta catenin protein 48 erythrocytes 48 synthetic retinoid 48 hepatocellular carcinomas 48 BRCA1 mutation 48 HCV replication 48 hematological malignancy 48 effector cells 48 myeloma cells 48 chronic HCV 48 placental malaria 48 serologic testing 48 bloodborne 48 cytokines IL 48 colorectal carcinomas 48 HBV replication 48 Multimeric 48 replicase 48 Mesothelin 48 prophylactic vaccines 48 inotropic 48 immunosuppressive therapies 48 Ad5 vector 48 transfusion transmitted 48 DGAT1 48 EGFR inhibitors 48 costimulatory molecules 48 quinolone resistant 48 MDM2 48 Treg cells 48 gene amplification 48 HCV infected 48 hepatocyte 48 PEG IFN 48 cyclin dependent kinase 48 NF kappaB activation 48 lupus nephritis 48 ERalpha 48 molecularly targeted 48 acute leukemias 48 lymphocyte 48 CTGF 48 CCR5 antagonist 48 TTR gene 48 Toxoid 48 activated lymphocytes 48 GPx 48 Hepatitis C virus 48 oncogenic HPV types 48 EphB4 48 Cloretazine 48 vWD 48 mtDNA mutations 48 Respiratory Syncytial Virus 48 CEACAM1 48 grade cervical dysplasia 48 protease inhibitors PIs 48 antiretroviral regimen 48 Elacytarabine 48 G CSF 48 Subtype 48 AV HALT 48 highly immunogenic 48 UPLYSO 48 HBV genotype 48 Immunosuppressive drugs 48 Salmonella spp 48 T#I [002] 48 meningococcus 48 neoplastic cells 48 Antibody 48 IGFBP 47 multidrug resistant 47 KLF4 47 glioma cells 47 PAR1 47 ERK5 47 PCR assay 47 TGF ß 47 MMP9 47 PTHrP 47 immunodeficient 47 breast cancer metastasis 47 leukemic stem cells 47 alpha#beta# integrin 47 recurrent glioblastoma multiforme 47 SOCS3 47 isoform 47 mycobacterial 47 herpes viruses 47 MGUS 47 immunosuppression 47 IgG1 antibody 47 Helicobacter 47 erythropoiesis 47 HCMV 47 e antigen HBeAg 47 smoldering myeloma 47 preclinically 47 NRTIs 47 influenzae 47 uPAR 47 carcinoembryonic antigen 47 induce apoptosis 47 NEUGENE 47 Raltegravir 47 CD4 + T lymphocytes 47 induces antibodies 47 Immune responses 47 NGAL 47 hepatocellular carcinoma 47 cytomegalovirus infection 47 IFN γ 47 ritonavir boosted protease inhibitor 47 medulloblastoma 47 Hepatitis B virus HBV 47 HDAC2 47 eotaxin 47 targeting CD# 47 Cervista HPV HR 47 Chlamydia pneumoniae 47 human papillomaviruses HPV 47 staphylococcal 47 CanAg 47 inhibit viral replication 47 ano genital warts 47 HPV Human Papillomavirus 47 IGF 1R 47 AT1R 47 measles virus 47 IgA 47 eNOS 47 hemodilution 47 cytokeratin 47 mucosal 47 Hemophilia B 47 Epstein Barr Virus EBV 47 bacterium Neisseria meningitidis 47 Oritavancin 47 E#F# 47 μg ml 47 orchitis 47 mutations 47 Kaposi sarcoma 47 BRSV 47 neutralizing antibody responses 47 Human Papilloma Virus HPV 47 aneuploidy 47 HPV types 47 HCV genotypes 47 ADAMTS# 47 grade cervical intraepithelial 47 topoisomerase 47 lymphocyte counts 47 murine leukemia virus 47 E7 proteins 47 HGPIN 47 bivalent 47 DAS# [001] 47 P#X# 47 Tarvacin 47 S. pyogenes 47 neural progenitor cells 47 CTAP# Capsules 47 Treg cell 47 IL6 47 mucosal immunity 47 microglial activation 47 latent infection 47 HAART 47 GISTs 47 HBV vaccination 47 transfected cells 47 oncogenic 47 volociximab 47 tumor antigens 47 PROCHYMAL 47 Hepatitis C Virus HCV 47 TLR7 47 Pegylated Interferon 47 B lymphocytes 47 RSV 47 GPR# [002] 47 interferon gamma 47 adaptive immunity 47 COL#A# 47 GIST tumors 47 IL #R 47 non nucleoside 47 glucocorticoid 47 ligase 47 sDNA 47 GHRH 47 nucleoside reverse transcriptase inhibitor 47 raltegravir 47 cells hESCs 47 HIV integrase inhibitor 47 torezolid 47 systemic amyloidosis 47 BCR ABL protein 47 viral load 47 EBV infection 47 congenital adrenal hyperplasia CAH 47 Sym# 47 lymphoid malignancies 47 nonvaccine 47 Varicella zoster virus 47 human herpesvirus 47 abacavir Ziagen 47 HDAC 47 MRSA colonization 47 flavopiridol 47 Malaria parasite 47 virological failure 47 genital HPV infection 47 Poliovirus 47 daclizumab 47 spontaneous preterm delivery 47 gonorrhoeae 47 costimulation 47 gene BRCA2 47 5alpha reductase 47 adefovir 47 Tregs 47 CD8 T 47 murine mouse 47 viral antigen 47 REYATAZ ® 47 metastatic renal cell carcinoma 47 S. aureus bacteria 47 HIV coinfected 47 oncoproteins 47 EGFR antibodies 47 streptococcal 47 OMP #M# 47 cervical cytology 47 Hepatitis C Virus 47 Lymphocytic 47 clade B 47 calcineurin inhibitors 47 Mycobacterium tuberculosis 47 immune modulators 47 GnRH antagonist 47 E. faecalis 47 OvaRex MAb 47 genital ulcer 47 acellular vaccine 47 simplex virus 47 missense mutations 47 Th2 47 decitabine 47 LQTS 47 hematopoietic cells 47 Hepatitis C virus HCV 47 talabostat 47 protein tyrosine phosphatase 47 Vidofludimus 47 mucosal immune responses 47 oesophageal adenocarcinoma 47 EGFR tyrosine kinase inhibitors 47 chlamydia trachomatis 47 reverse transcriptase enzyme 47 mycobacterium tuberculosis 47 macrolide resistance 47 basal cell carcinoma BCC 47 IgE 47 PRRSV 47 boosted protease inhibitor 47 BRCA2 gene mutation 47 Opportunistic infections 47 Notch signaling 47 NS5b 47 P aeruginosa 47 Decitabine 47 NFκB 47 Alferon N 47 serogroup B 47 chemotherapeutic agents 47 HLA molecules 47 CpG 47 pneumococcal bacteria 47 Parvovirus B# 47 viral antigens 47 neoplastic 47 mitochondrial enzyme 47 cervical vaginal 47 SOX9 47 human papillomavirus HPV 47 HuMax CD4 47 Interferon alfa 47 deacetylation 47 protease inhibitor PI 47 Protease Inhibitors 47 AZT 3TC 47 Enzastaurin 47 thymosin 47 Beta catenin pathway 47 AZT zidovudine Retrovir 47 bacterial colonization 47 TTR amyloidosis 47 Aptivus ® 46 beta thalassemia 46 STAT3 signaling 46 HAART regimens 46 inactivated vaccine 46 HBeAg positive 46 cytokine 46 FVIII 46 PREVNAR 46 TGF beta 46 virologic responses 46 C. difficile toxins 46 PPARγ 46 ADAM# 46 suppressor cells 46 malignant transformation 46 BARACLUDE ® 46 xenograft models 46 Disease Progression 46 LRP5 46 ELISPOT assay 46 endometritis 46 EZH2 46 LPS induced 46 bendamustine 46 Th2 cells 46 virotherapy 46 thyrotropin 46 stem cell mobilizer 46 allelic variants 46 investigational integrase inhibitor 46 Ki# 46 nucleoside analogs 46 anal HPV 46 P selectin 46 viral replication 46 Monocyte 46 Vesivirus 46 hemagglutination inhibition 46 CXCL# 46 E1A 46 pneumococcal pneumonia 46 GBV C 46 selective agonist 46 Prophylaxis 46 IL# [001] 46 herpes simplex 46 Oncogenic 46 colorectal adenoma 46 biochemical relapse 46 receptor tyrosine kinase inhibitor 46 TH# cells 46 immunodeficiency 46 nucleolin 46 Twinrix 46 OncoVEX 46 Blinatumomab 46 eIF2 46 TRAIL induced apoptosis 46 Apaziquone 46 CERVARIX 46 Cdc7 46 granzyme B 46 NKG2D 46 NOD2 46 Aß 46 microglial cells 46 infectious mononucleosis 46 polymorphisms 46 CEQ# 46 OncoVEX GM CSF 46 hypovitaminosis D 46 biologic DMARD 46 immunologic 46 microvessel density 46 PTP 1B 46 TLR4 46 Antiviral Activity 46 interleukin IL -# 46 paratuberculosis 46 huC# DM4 46 JAK2 V#F 46 Traficet EN 46 Monoclonal 46 JAK inhibitors 46 ERK1 2 46 null mice 46 inflammatory demyelinating 46 immunomodulatory therapy 46 lymphomas 46 MDR1 46 APOE e4 46 mycophenolate mofetil 46 CYT# 46 endometrial ovarian 46 T. cruzi 46 Cytotoxic T 46 HCV genotype 46 pulmonary TB 46 hepatic 46 staphylococci 46 recurrent metastatic 46 bacterial pathogen 46 MCADD 46 testicular germ cell 46 S.aureus 46 cyclin E 46 Clevudine 46 elacytarabine 46 natriuretic peptide 46 urethritis 46 metastatic RCC 46 mineralocorticoid receptor 46 Latent TB 46 human immunodeficiency 46 Th1 cells 46 potent antiretroviral therapy 46 peginterferon 46 miR #a [002] 46 MenACWY 46 CK2 46 ascending doses 46 lymphoid tissues 46 Cardiotoxicity 46 TGF β1 46 malarial parasites 46 CCR2 46 Boceprevir 46 Eg5 46 FVIIa 46 precancerous cervical lesions 46 Akt activation 46 overexpression 46 viral subtypes 46 Glufosfamide 46 Six3 46 hepatocellular cancer 46 IGF IR 46 MCAD deficiency 46 gonadotropins 46 Shigella bacteria 46 TB bacilli 46 diphtheria tetanus pertussis 46 mammaglobin 46 GSK3 46 Intercell vaccine 46 CYP# [002] 46 LB# [003] 46 TH1 46 immunologically 46 viral vector 46 carcinoid tumors 46 Kupffer cells 46 multidrug resistant strains 46 R. equi 46 B7 H1 46 hepatitis C virus HCV 46 recurrent genital herpes 46 Daclizumab 46 GRP# 46 feline calicivirus 46 Ankara MVA 46 acellular pertussis DTaP 46 Menveo 46 hematopoietic 46 Smad3 46 somatic mutations 46 M2 subunit 46 cells PBMC 46 adenovirus vector 46 T#I mutation 46 annexin V 46 tumorigenic 46 Epstein Barr Virus 46 tipranavir ritonavir 46 Wwox 46 pharmacodynamic PD 46 monocytes macrophages 46 CCR5 receptor antagonist 46 myeloid cells 46 Nanobodies 46 busulfan 46 Azixa 46 toxoplasmosis 46 IFN beta 46 CCR5 antagonists 46 potent inhibitory 46 hypothalamic pituitary adrenal axis 46 Pim kinases 46 pneumococcal infections 46 MECP2 gene